Skip to content
  • Knowledge Hub
  • Careers
  • News & Events
  • Contact Us
CatSci CatSci
  • Home
  • Who we are
  • What we do
    • Small Molecule
      Early Development
    • Small Molecule
      Late Development
    • Route Scouting and Selection
    • High Potency APIs
    • Solid State & Preformulation
    • Analytical Science
    • Separation Science
    • Oligonucleotides
  • SmartPath
  • Digital Walkthrough
  • Knowledge Hub
  • Careers
  • News & Events
  • Contact Us

Catalysis

Categories
BlogBook ChaptersCase StudiesPapersPatentsPresentationsThought LeadersWebinarsWhitepapers
Tags
Analytical Chemistry Analytical Science Artificial Intelligence (AI) Biocatalysis Catalysis CatSci Paper CatSci Patent Chemical Development Design of Experiments Digital Drug Development Experimental Design Green Chemistry Industry insights Innovation Machine Learning (ML) Material Science Medium Throughput Experimentation Oligonucleotides Principal Component Analysis Process R&D PROTACs QbD Route Scouting and Selection Scale-up Scavenging Solvents Sustainability Technology transfer Work-up
Metal Control Strategy in Drug Development: The Importance of Getting It Right

Our Director of Analytical Science, Sam Whitmarsh, and our Director of Chemical Science, Rob Crook describe CatSci's robust metal control strategies and workflows that ensure alignment with the ICHQ3D requirements and ultimately patient safety.

Apr 3rd 2024 By Rob CrookSam Whitmarsh
Application of the Polonovski Reaction: Scale-up of an Efficient and Environmentally Benign ...

Org. Process Res. Dev. 2022, 26, 5, 1398–1404

2022 By Antonio M. RudaSiân M. ForsythSofia PapadouliVargini Thangavadivale, et al.
Development of a Process to a 4-Arylated 2-Methylisoquinolin-1(2H)-one for the Treatment of ...

Org. Process Res. Dev. 2022, 26, 5, 1458–1469

2022 By Antonio M. RudaSiân M. Forsyth, et al.
Chemistry Today: Panel Discussion on Catalysis

CatSci's Senior Scientist, Dr Alice Dunbabin, participated in the latest Chemistry Today panel discussion on Catalysis.

2022 By Alice Dunbabin
The Next Decade of Drug Development 

Access the recordings of our 10-year anniversary symposium now. The event was centred on the future of medicines development and featured industry-leading speakers from AstraZeneca, Bristol Myers Squibb, DeepMatter, FogPharma, Merck, Novartis, R.I, Roche, Syngenta, and more.

2021
Faster, Cleaner and Greener: An Introduction to Micellar Catalysis for Medicine Development

Find out more about micellar catalysis, including its environmental, economic and productivity benefits.

Aug 3rd 2021 By Alan Steven
The Medicine Maker: Are You a Bio-Catalytic Converter?

Speed and efficiency are everything in pharmaceutical synthesis – and that’s why biocatalysis is an increasingly attractive option.

2021 By Alice Dunbabin
Method Development for High Throughput Sample Analysis

CatSci was tasked with catalyst screening for an asymmetrical hydrogenation of a target.

2021 By Siân M. ForsythBeth Rees-HindleyGareth Tutton
Metal Scavenging Whitepaper

Development of a flow scavenging protocol

2021 By CatSci team
The Small Molecule Manufacturer: Solvents – Making the Green Choice

Dr Alan Steven explains why environmental sustainability and “big picture thinking” should be key considerations when selecting solvents for scale-up.

2021 By Alan Steven
Designing a Robust Scalable Catalytic Process

The client's Phase 1 process was struggling to deliver API in low kg qualities. In particular, Intermediate B was of variable quality, and residual metals were known to negatively affect the onward chemistry.

2020 By Vargini ThangavadivaleDan A. SmithSiân M. Forsyth
Development of a Late-Stage Buchwald Amination

CatSci was tasked with the development of a regioselective Buchwald-Hartwig amination for the final bond forming step of an API. The inherited conditions were not robust with respect to reaction conversion leading to stability concerns.

2020 By Siân M. ForsythBeth Rees-HindleyJonathan D. MoseleyJoseph Renny
Process for the preparation of bromodomain inhibitor

WO2020023438

2020 By Antonio M. Ruda, et al.
Selective Catalytic Synthesis of 1,2- and 8,9-Cyclic Limonene Carbonates as Versatile Buildi...

Chem. Eur. J., 2020, 26, 1–12

2020 By Marc Hutchby, et al.
Mapping the properties of bidentate ligands with calculated descriptors (LKB-bid)

Dalton Trans., 2020, 49, 8169-8178

2020 By Simon N. G. Tyler, et al.
Ketone Reductase Biocatalysis in the Synthesis of Chiral Intermediates Toward Generic Active...

Org. Process Res. Dev. 2020, 24, 6, 1131–1140

2020 By Dan A. SmithJoanne B. SampsonSiân M. Forsyth, et al.
Chemistry Today: Panel Discussion on Catalysis

Our Associate Principal Scientist, Dr Vargini Thangavadivale participated in the latest Chemistry Today panel discussion on catalysis

2020 By Vargini Thangavadivale
Sustainable catalytic protocols for the solvent free epoxidation and anti-dihydroxylation of...

Green Chem., 2020, 22, 513-524

2019 By Marc Hutchby, et al.
Catalysis Technical Piece

A general approach to the optimisation of Buchwald-Hartwig aminations for organic chemists

2019 By CatSci team
Biocatalysis Whitepaper – Lipases

Development of a DKR for the manufacture of (S)-Flurbiprofen

2018 By CatSci team
Opinion Piece – Why Biocatalysis?

Why Biocatalysis?

2018 By CatSci team
1 2 Next »

Helpful Links

  • Contact Us
  • Careers
  • Safety, Health and Environment
  • Privacy Policy
  • CatSci Corporate and Social Responsibility (CSR) Policy
  • Sustainability Report 2024

What we do

  • Small Molecule Late Development
  • Small Molecule Early Development
  • Route Scouting and Selection
  • Analytical Science
  • High Potency APIs
  • Solid State and Preformulation
  • Oligonucleotides

Who we are

CatSci Ltd are an award-winning innovation partner for medicines development who are committed to creating tailored solutions from candidate selection through product launch and beyond. We break down the silos in small molecules, TACS, glues and oligonucleotides CMC development to accelerate the delivery of life-changing medicines to patients in need. 

© 2025 CatSci Ltd. All rights reserved.
Registered in England & Wales.
Company No. 07466141.